Status:
UNKNOWN
Use of Ascorbic Acid in Patients With COVID 19
Lead Sponsor:
University of Palermo
Conditions:
Hospitalized Patients With Covid-19 Pneumonia
Eligibility:
All Genders
Phase:
NA
Brief Summary
Different studies showed that ascorbic acid (vitaminC) positively affects the development and maturation of T-lymphocytes, in particular NK (natural Killer) cells involved in the immune response to vi...
Detailed Description
The Sars-COV-2, has spread all over the world, in two months after its discovery in China. Outbreaks have been reported in more than 50 countries with more than 118,223 confirmed cases and 4,291 death...
Eligibility Criteria
Inclusion
- In case of doubt of interstitial pneumonia with indications for intubation
- Positive swab test of SARS-CoV-2
- Interstitial pneumonia
- Signature of informed consent
Exclusion
- Unsigned informed consent
- Negative swab test of SARS-CoV-2
Key Trial Info
Start Date :
March 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 13 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04323514
Start Date
March 13 2020
End Date
March 13 2021
Last Update
March 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
A.R.N.A.S. Civico - Di Cristina - Benfratelli
Palermo, Italy, 90127